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Tbjective: Calcification is the main cause of structural valve deterioration; however,
ther causes of failure have been identified, and among them, dehiscence of a
ommissure from the stent has been reported in several models of porcine valves.
he aim of this study was to analyze the rate and mode of occurrence of this
omplication in first- and second-generation porcine bioprosthetic explants.
ethods: Among 586 porcine xenografts explanted and analyzed at the Institute of
athological Anatomy of the University of Padua, 17 (2.9%) have been replaced for
ncompetence because of commissural dehiscence. All these explants were in the
itral position, with the exception of a Carpentier-Edwards supra-annular aortic
alve prosthesis.
esults: Dehiscence was observed in 9 (1.9%) of 455 Hancock standard explants, in
(3.2%) of 31 Hancock II, in 3 (8.6%, 2 standard and 1 supra-annular) of 35
arpentier-Edwards, in 1 (2.4%) of 42 Bioimplants, and in 3 (50%) of 6 Xenotech
fter a mean time function of 157  50, 156, 96  29, 143, and 130  8 months,
espectively. Dehiscence was the sole cause of incompetence in 6 cases. An
mpending commissural dehiscence caused by blood creeping was observed in one
ase. This might be an explanation for the dehiscence other than excessive trimming
f the aortic wall.
onclusions: Commissural dehiscence is an uncommon and peculiar mode of failure
f porcine valves implanted in the mitral position and was observed earlier and more
requently with Carpentier-Edwards porcine explants (P  .05). We speculate that
ericardial strip protection of the suture between the Dacron fabric and porcine
ortic wall, as used in the Biocor porcine valve, might prevent this complication.
issue valve xenografts have been implanted for more than 40 years, and
different generations of porcine bioprostheses have been available. The first
generation failed mostly because of calcification and suboptimal valve de-
ign. Then several improvements, such as supra-annular configuration, stent flexi-
ility, low-pressure glutaraldehyde fixation, strut height reduction, new methods of
issue preservation, and calcium retardant agents, have been introduced,1-3 thus
nhancing their function and retarding structural valve deterioration (SVD). How-
ver, manufacturing factors have seldom been implicated as a direct cause of SVD.
he dehiscence of a commissure, namely the commissural detachment of the
orcine aortic wall from the stent post, leading to a cusp prolapse and regurgitation,
as been reported in first-generation (Carpentier-Edwards standard and Hancock
tandard)4,5 and second-generation (Carpentier-Edwards supra-annular, Medtron
ntact, and Hancock II) porcine valves.1,6,7
By using an implant retrieval analysis of all types of bioprostheses implanted at
he University of Padua, we investigated the occurrence of commissural dehiscence
s a cause of valve incompetence in various valve explants.
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CDaterials and Methods
etween January 1970 and January 2004, 2212 patients underwent
eart valve replacement with valve xenografts. The majority of the
issue valves used were porcine bioprostheses (1676 porcine vs
36 pericardial). Concerning the porcine valves in the aortic po-
ition, the distribution was as follows: 39% Hancock valves (1970-
000), 47% Biocor valves (1990-2005), and 4% Carpentier-Edwards
tandard and supra-annular valves (1980-1990), and the remaining
ere other models, such as Labcor, SJM X-cell, Bioimplant, and
enotech valves. On the contrary, in the mitral position the dis-
ribution was as follows: 68% Hancock valves (1970-2000), 18%
iocor (1990-2005), and 8% Carpentier-Edwards standard and
upra-annular (1980-1990), and the remaining were other models,
uch as Bioimplant, Xenotech, Labcor, and Angell-Shiley valves.
he mean age of the patients at the time of the operation was 65
0 years, and 54% were female. Five hundred eighty-six porcine
ioprostheses have been explanted at reoperation and retained for
athologic study. The protocol of the investigation consisted of
ross examination, photography of the specimens with a stereo-
cope, and radiography for a semiquantitative analysis of Ca
eposits using a 0- to 4-point scale, as previously reported.8 All the
alves were examined in each case at the time of explantation by
he same pathologist (GT) with long-term experience in this field,
ho was skilled enough to rule out surgical manipulations. Each
alve was sent to the pathologist with an attached surgical report.
here were 538 first-generation porcine bioprostheses (455 Hancock
tandard, 35 Carpentier-Edwards [26 standard and 9 supra-annular],
2 Bioimplant, and 6 Xenotech) and 48 second-generation porcine
ioprostheses (31 Hancock II and 17 Biocor). Details are summa-
ized in Table 1. Four hundred thirty-six were mitral, 136 
ortic, and 14 were tricuspid bioprostheses. Four hundred eighty
rostheses were in place for less than 15 years, and the remaining
06 were in place for more than 15 years.
In the entire series of explants, 17 (2.9%) bioprostheses have
een replaced for incompetence because of a peculiar type of SVD,
amely commissural dehiscence.
The incidence of commissural dehiscence in the aortic and
itral position and among different valve models was compared
y using the Fisher exact test.
Abbreviations and Acronyms
SVD structural valve deterioration
ABLE 1. Explanted bioprostheses
odel No. Aortic Mi
ancock standard 455 104 (106 50) 338 (125
ancock II 31 6 (118 56) 24 (101
arpentier-Edwards 35 15 (122 50) 20 (117
ioimplant 42 3 (60  35) 39 (96.
enotech 6 0 6 (113
iocor 17 8 (10  5) 9 (16
otal 586 136 4ime of function in months is shown in parentheses. *All mitral cases with the
018 The Journal of Thoracic and Cardiovascular Surgery ● Nove
esults
ixteen bioprostheses with a dehiscent commissure were
xplanted from the mitral position (28-33 mm range of label
ize), and only 1 (Carpentier-Edwards supra-annular) was
xplanted from the aortic position (23 mm; P  .005).
welve were implanted in female subjects (mean age,
5.5  10 years), and 5 were implanted in male subjects
mean age, 63.8  6 years).
acroscopic Examination
he commissural dehiscence rate is reported in Table 1
t was significantly more frequent in Carpentier-Edwards
nd Xenotech prostheses (P  .05). Commissural dehis-
ence, with (4 cases) or without (2 cases) calcification, was
he sole cause of dysfunction in 6 cases after a mean period
f function of 187  62 months (Figures 1 and 2). In 
emaining 11 explants, tears and wears were concomitantly
resent (mean time of function, 159  35 months), with (8
ases) or without (3 cases) calcification. Dehiscence oc-
urred at the anterior commissure (ie, between the right and
eft cusps) in 13 explants (Table 2).
In 2 prostheses (1 Hancock standard and 1 Xenotech)
ehiscence was concomitantly present in 2 different com-
issural posts; in the Xenotech valve the dehiscence of the
nterior commissure was associated with a hematoma of the
eft posterior commissure, with evidence of incipient de-
achment (Figure 3).
ime of Function of Different Prosthesis Models
ommissural detachment of the aortic wall occurred after a
ean time of 157  50 months in Hancock standard ex-
lants, 156 months in Hancock II explants, 96  29 months
n Carpentier-Edwards (standard and supra-annular) ex-
lants, 143 months in the Bioimplant, and 130  8 months
n the Xenotech. Therefore commissural dehiscence oc-
urred earlier in the Carpentier-Edwards prostheses than in
thers (P .05). Of the 3 Carpentier-Edwards prostheses, 2
ere standard models implanted in the mitral position in
980 and 1984, and one was a supra-annular model im-
lanted in the aortic position in 1986.
Tricuspid Dehiscence rate* P value
2) 13 (143  49) 9/455, 2% (157 50) NS
4.5) 1 (126) 1/31, 3.2% (156) NS
0) 0 3/35, 8.6% (96  29) .05
1.4) 0 1/42, 2.4% (143) NS
6.5) 0 3/6, 50% (130 80) .05
0 0/17, 0% —
14 17 (2.9%)tral
 5
 5
 5
4 3
 3
 7)
36exception of 1 Carpentier-Edwards supra-annular valve aortic prosthesis.
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CDadiographic Findings
wo prostheses showed no signs of calcification (score 0 at
adiography) after 102 months (Carpentier-Edwards stan-
ard, Figure 1) and 160 months (Hancock standard), res
ively. Eleven prostheses showed initial signs of commis-
ural mineralization (score, 1-2) at a mean time of 163 50
onths (range, 106-260 months). Four tissue valves showed
eavy mineralization at a mean time of 151  71 months
score, 3-4; Figure 4).
iscussion
mong 586 porcine bioprostheses explanted at reoperation
t our institute, 496 (85%) have been replaced as a result of
VD, mostly because of dystrophic calcification.9 Seven-
een porcine valve xenografts failed because of a detach-
ent of the porcine aortic wall from the stent at the top of
he commissural post, so-called commissural dehiscence4
SVD has been extensively documented as the major
omplication of porcine bioprostheses.7,8 However, it ha
eldom been attributed to a specific manufacturing cause.
istal and coworkers4 first ascribed the cause of comm-
ural dehiscence of Carpentier-Edwards porcine valve mod-
ls to a manufacturing flaw. According to their results, the
Figure 1. Dehiscence at the anterior commissure in a
102 months in the absence of calcification.The Journal of Thoracicommissural dehiscence occurred frequently in those mod-
ls because of an excessive trimming of the outer layers of
he porcine aortic wall accomplished to favor the hemody-
amic performance. This manufacturing improvement was
ntroduced in 1986 in the large mitral prostheses, and in
987, this practice was extended to all sizes of mitral and
ortic prostheses.10 Moreover, the major stress sustained 
he mitral position was an additional risk factor explaining
he higher incidence of commissural dehiscence in mitral
ioprostheses.4,11 Also, in the experience of Jamieson 
olleagues,1 commissural dehiscence occurred mostly 
itral prostheses, namely 29 (14%) of 205 explants and
nly 1 case in the aortic position (1/81 [1.2%] explants).
he average time of function of the affected mitral prosthe-
es was 102.9 months (range, 44.7-162.7 months), whereas
ommissural dehiscence occurred as late as 172 months in
he single affected aortic bioprosthesis. In their series 28 of
9 mitral prostheses were second-generation Carpentier-
dwards porcine valves implanted between 1982 and
986. Concerning position and timing, our results are
ery similar to those reported by Jamieson and col-
eagues.1 These authors, as well as Kimura and ass-
l Carpentier-Edwards standard prosthesis in place for
Figure 2. Dehiscence at the anterior
commissure in a mitral Hancock stan-
dard prosthesis in place for 225
months. Mild calcific deposits were
seen at radiography.mitraand Cardiovascular Surgery ● Volume 132, Number 5 1019
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CDtes,12 concluded that the modifications introduced 
he second-generation Carpentier-Edwards supra-annular
odel did not improve the durability over the first-
eneration standard valve. The Vancouver group recently
eported follow-up to 18 years of the Carpentier-Edwards
upra-annular porcine valve in the mitral position and found
hat commissural dehiscence accounted for 19% of incom-
etence (39 of 204 explants with incompetence).13
However, this complication was not unique to the
arpentier-Edwards porcine valve because it has been ob-
erved also in other second-generation porcine bioprostheses,
uch as the Hancock II7 and the Medtronic Intact.6,14 In these
alves aortic wall trimming was not performed, casting
oubt on the offered explanation. The Hancock II porcine
ioprosthesis was introduced in 1982, with some modifica-
ABLE 2. Porcine bioprostheses with commissural dehisc
odel/ID Position Months* R
ancock S. 29 mm Mitral 141
ancock S. 29 mm Mitral 160
ancock S. 29 mm Mitral 216
ancock S. 31 mm Mitral 106
ancock S. 29 mm Mitral 172
ancock S. 31 mm Mitral 260
ancock S. 31 mm Mitral 236
ancock S. 31 mm Mitral 164
ancock S. 33 mm Mitral 225
ancock II 29 mm Mitral 156
arpentier-Edwards standard 29 mm Mitral 102
arpentier-Edwards standard 31 mm Mitral 64
arpentier-Edwards SAV 23 mm Aortic 122
enotech 29 mm Mitral 138
enotech 31 mm Mitral 132
enotech 33 mm Mitral 122
ioimplant 28 mm Mitral 143
AV, supraannular valve. *Time of function.020 The Journal of Thoracic and Cardiovascular Surgery ● Novions aimed to improve durability over the Hancock stan-
ard bioprosthesis, and such improvements have been con-
rmed in clinical and pathologic studies.2,3,7,15,16 Among 31
ancock II bioprostheses explanted (our series), a commis-
ural dehiscence not related to calcification or infection was
he cause of incompetence in a mitral prosthesis at 156
onths after implantation.
Our data confirm the higher incidence of cusp dehiscence
n the mitral prostheses, and in agreement with the echo-
ardiographic study of Naqvi and coworkers,17 the commis-
ure mostly affected was the anterior commissure, the one
hat probably supports the higher stress. Only twice have 2
ommissures appeared detached, which means that a single
ehiscent commissure with double-cusp prolapse might
ause a significant valve incompetence requiring valve re-
Figure 3. Double commissural dehis-
cence in a Xenotech mitral valve: one
overt and one impending with a hema-
toma (arrow).
raphy score Site of commissural dehiscence
3 Anterior commissural dehiscence
0 Double commissural dehiscence
(anterior and left posterior)
2 Anterior commissural dehiscence
1 Anterior commissural dehiscence
1 Anterior commissural dehiscence
2 Left posterior commissural dehiscence
4 Anterior commissural dehiscence
3 Right posterior commissural dehiscence
2 Anterior commissural dehiscence
2 Left posterior commissural dehiscence
0 Anterior commissural dehiscence
3 Left posterior commissural dehiscence
1 Anterior commissural dehiscence
1 Anterior commissural dehiscence
2 Double commissural dehiscence (anterior and left
posterior), the latter with swelling hematoma
1 Anterior commissural dehiscence
1 Anterior commissural dehiscenceence
adiogember 2006
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A
CDlacement. As previously described,4 at the time of gro
xamination, the attachment of porcine cusps to the aortic
all at the commissure appeared intact, whereas it was the
ortic wall that was completely detached from the stent post.
t radiography, mineral deposits in the valve specimens
ere minimal or absent in 6 patients, thus proving that this
ommissural complication can occur solely and lead to
alve dysfunction per se.
We share the current opinion that an excessive trimming
f the aortic wall leads to weakening of the commissure and
o an increased risk of dehiscence of the aortic wall from the
tent post caused by mechanical stress. Nevertheless, com-
issural dehiscence, at a lower rate, occurred also in the
ancock II and Medtronic Intact bioprostheses, which do
ot undergo aortic wall trimming. Therefore other reasons
ight be applicable. Most of the porcine bioprostheses have
similar commissural suspension based on the suturing of
he aortic wall to the fabric-covered stent. An infiltration of
lood behind the commissure might create a hematoma, which,
y means of progressive swelling, might detach the commis-
ure, as in the case of the Xenotech prosthesis (Figur
uspal hematoma has been reported as a rare complication
ausing valve stenosis as a result of blood infiltration at the
asal cusp suturing, accounting for hematoma dissection.18
The Biocor prosthesis has a pericardial shield tailored to
over the superior profile of the junction between stent–
abric–aortic wall and sutured between the inner and the outer
ide of the stent,19 thus preventing this complication (Figure 
umber and time of function of Biocor explants in our
eries of both aortic19 and mitral valve replacement,20 in
hich no commissural dehiscence occurred, was too short
o confirm this hypothesis, and therefore pathologic studies
n long-term explants are mandatory. However, it is fun-
amental to add to these considerations that (1) in both
ur studies19,20 freedoms from SVD were calculate
Figure 4. Commissural dehiscence and heavy minerali
prosthesis implanted in 1984 and in place for 64 montncluding also the echocardiographic results; (2) only 3 a
The Journal of Thoracic).
VD cases were observed for the aortic valves and none for
he mitral valves at 8-year follow-up; and (3) in no patient
as a commissural dehiscence observed at 2-dimensional
chocardiography.
n with tears in a mitral Carpentier-Edwards standard
core was 4 at radiography.
igure 5. Drawing depicting a Biocor valve. Note that a pericar-
ial sheet covers the superior profile of the stent to which thezatio
hs. Sortic wall and the fabric are sutured.
and Cardiovascular Surgery ● Volume 132, Number 5 1021
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CDonclusions
ommissural dehiscence from the stent post in the porcine
alves is a peculiar and uncommon cause of dysfunction
ccurring in 2.9% of explants. It was observed mainly in the
itral position, and it was responsible for valve incompe-
ence severe enough to require a reoperation. In our expe-
ience, among various models, commissural dehiscence was
bserved earlier and more frequently in Carpentier-Edwards
orcine valve explants. Manufacturing solutions, such as
hose introduced in the second-generation Biocor porcine
rostheses, might prevent or reduce this complication.
We thank Mr Nicola Paccagnella for his assistance in preparing
he figures and Mrs Chiara Carturan for editing the manuscript.
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